← Back to Search

Single-arm for Lung Cancer (LC-PRO Trial)

N/A

Waitlist Available

Led By Gita Mody, MD, MPH

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

LC-PRO Trial Summary

This trial is testing whether Moovcare®, a mobile medical application, can help monitor Patient-Reported Outcomes (PROs) related to cancer treatment, cancer complications, and cancer relapse in patients with lung cancer. PROs are symptoms directly reported by patients.

Eligible Conditions

Lung Cancer

LC-PRO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of Self-reporting Symptoms Using Moovcare®

Secondary outcome measures

Change in Health-related Quality of Life Lung Specific

Health-related Quality of Life Change

Overall Survival

+2 more

LC-PRO Trial Design

1Treatment groups

Experimental Treatment

Group I: Single-armExperimental Treatment1 Intervention

Participants will be assigned to the single-arm involving weekly monitoring of their patient-reported outcomes using Moovcare®.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Moovcare® use

2021

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor

351 Previous Clinical Trials

88,291 Total Patients Enrolled

Sivan Innovation Ltd.UNKNOWN

Gita Mody, MD, MPHPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

2 Previous Clinical Trials

313 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research involve individuals who are past their sixtieth birthdays?

"Those eligible for this clinical trial must be 18 years old or older and not yet reached the age of 99."

Answered by AI

Are there any prerequisites to participating in this medical experiment?

"According to this research, enrollees must have a neoplasm in their lung and be aged between 18-99. The trial is recruiting up to 42 participants."

Answered by AI

Is enrollment still attainable in this research project?

"As per the information published on clinicaltrials.gov, this medical study is no longer recruiting participants. It was first posted in September 2021 and its most recent update came in July 2022; however, 3926 other trials are presently looking for patients as of now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®

2021. "Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05011890.